Live from the NIH registry
Studies recruiting near Wichita right now
Top 25 of 162 recruiting studies, sorted by proximity — each links to its official registry page
Cephea Early Feasibility Study
Mitral Regurgitation
N/A
Interventional 90 participants sought
Ascension Via Christi Hospitals Wichita — Wichita, Kansas (0.4 mi)
· Sponsor: Abbott Medical Devices
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Chronic Idiopathic Constipation (CIC)
Phase 3
Interventional 692 participants sought
Tekton Research - Wichita, KS — Wichita, Kansas (0.4 mi)
· Sponsor: Ardelyx
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma
Phase 3
Interventional 5,951 participants sought
Wesley Medical Center — Wichita, Kansas (0.4 mi)
· Sponsor: Children's Oncology Group
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Non-small Cell Lung Cancer
Phase 3
Interventional 1,000 participants sought
Cancer Center of Kansas — Wichita, Kansas (0.4 mi)
· Sponsor: Bristol-Myers Squibb
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Phase 3
Interventional 4,200 participants sought
Kansas Nephrology Research Institute, LLC — Wichita, Kansas (0.4 mi)
· Sponsor: Boehringer Ingelheim
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Phase 3
Interventional 250 participants sought
Wichita Urology Group — Wichita, Kansas (0.4 mi)
· Sponsor: Ferring Pharmaceuticals
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 3
Interventional 1,100 participants sought
AMR Wichita East, KS (Heartland Research Associates) — Wichita, Kansas (0.4 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Colorectal Neoplasms
Phase 3
Interventional 1,000 participants sought
Cancer Center of Kansas — Wichita, Kansas (0.4 mi)
· Sponsor: Janssen Research & Development, LLC
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Obesity, Overweight
Phase 3
Interventional 3,600 participants sought
ACCOMPLISH-1 Research Site — Wichita, Kansas (0.4 mi)
· Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
N/A
Interventional 9,500 participants sought
Robert J Dole VA Medical Center — Wichita, Kansas (0.4 mi)
· Sponsor: NRG Oncology
Pan-tumor MRD Study
Muscle Invasive Bladder Urothelial Carcinoma, Esophageal Cancer
N/A
Observational 1,350 participants sought
Cancer Center of Kansas — Wichita, Kansas (0.4 mi)
· Sponsor: Paradigm Health
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Phase 2, Phase 3
Interventional 1,092 participants sought
Kansas Gastroenterology, LLC — Wichita, Kansas (0.4 mi)
· Sponsor: Janssen Research & Development, LLC
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
Focal Segmental Glomerulosclerosis
Phase 3
Interventional 286 participants sought
Wichita Nephrology Group — Wichita, Kansas (0.4 mi)
· Sponsor: Boehringer Ingelheim
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves
Aortic Valve Insufficiency, Aortic Valve Stenosis
N/A
Interventional 200 participants sought
Ascension Via Christi St. Francis (Cardiovascular Research Institute of Kansas) — Wichita, Kansas (0.4 mi)
· Sponsor: Edwards Lifesciences
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Clostridium Difficile, Clostridium Difficile Infections
Phase 3
Interventional 852 participants sought
IDC Clinical Research, LLC — Wichita, Kansas (0.4 mi)
· Sponsor: Vedanta Biosciences, Inc.
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Phase 3
Interventional 4,500 participants sought
AMR Clinical — El Dorado, Kansas (27.8 mi)
· Sponsor: Eli Lilly and Company
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
Obesity
Phase 3
Interventional 1,200 participants sought
Kailera Clinical Site — Newton, Kansas (24.7 mi)
· Sponsor: Kailera
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
N/A
Observational 5,000 participants sought
Associates In Womens Health — Wichita, Kansas (0.4 mi)
· Sponsor: National Cancer Institute LAO
Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer
Early-stage Breast Cancer, Hormone Receptor Positive Breast Carcinoma
Phase 2
Interventional 88 participants sought
Cancer Center of Kansas — Wichita, Kansas (0.4 mi)
· Sponsor: Jonsson Comprehensive Cancer Center
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Heart Failure
Phase 3
Interventional 6,712 participants sought
West Houston Area Clinical Trial Consultants, LLC - Wichita — Wichita, Kansas (0.4 mi)
· Sponsor: Boehringer Ingelheim
An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
Hypertension (HTN)
Phase 2
Interventional 323 participants sought
Alliance for Multispecialty Research — Wichita, Kansas (0.4 mi)
· Sponsor: Novartis Pharmaceuticals
PCOM2 - The Physician Communication Intervention, Version 2.0
HPV Infection, Preventive Health Services
N/A
Interventional 120 participants sought
University of Kansas Medical Center — Wichita, Kansas (0.4 mi)
· Sponsor: University of Colorado, Denver
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Moderately to Severely Active Crohns Disease
Phase 3
Interventional 600 participants sought
Kansas Gastroenterology, LLC under Clinical Trials Network — Wichita, Kansas (0.4 mi)
· Sponsor: Hoffmann-La Roche
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Cancer Center of Kansas — Wichita, Kansas (0.4 mi)
· Sponsor: Relay Therapeutics, Inc.
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Prostate Cancer, Prostatic Neoplasms
Phase 3
Interventional 383 participants sought
Wichita Urology Group — Wichita, Kansas (0.4 mi)
· Sponsor: Clarity Pharmaceuticals Ltd